Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 11/20 | 0.76 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.76 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5697890 | 1.00 | KCNA5 (0.76) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL5697855 | 0.91 | KCNA5 (0.63) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL5697897 | 0.91 | KCNA5 (0.63) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL5697886 | 0.91 | KCNA5 (0.63) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL2212471 | 0.86 | KCNA5 (1.00) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL498107 | 0.86 | KCNA5 (1.00) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL498106 | 0.86 | KCNA5 (1.00) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL13801062 | 0.85 | KCNA5 (0.82) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL5697901 | 0.83 | KCNA5 (0.56) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 | |
| SCHEMBL3162863 | 0.82 | KCNA5 (0.75) | KCNA5KCNA3TAS1R3TAS1R1KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4658919-B2 | — | — | 2011-03-23 | — | — | JP | claimed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | claimed |
| JP-2006520342-A | — | — | 2006-09-07 | — | — | JP | claimed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | claimed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | claimed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | claimed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | claimed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | claimed |
| EP-1605976-B1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-02-24 | — | — | EP | disclosed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | disclosed |
| EP-1222163-B1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-07-12 | — | — | EP | disclosed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | disclosed |
| EP-1222163-A1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | Aventis Pharma Deutschland GmbH (DE) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001025189-A1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-04-12 | — | — | WO | disclosed |